Wikipedia -WSS

Wikipedia

author：explore 2025-09-28 00:48:04 - browse：3

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： UnitedHealth, Optum discontinue NaviHealth name

focus

WSS

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Readout Newsletter: Biotech news today

STAT Summit: Ending the crisis of Black deaths in the U.S.

How AI can help patients find reliable information about doctors

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Newly revealed memo details efforts to keep Trump in power following election loss

entertainment

Wikipedia

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Summit: Meghan O’Rourke on making chronic illness visible

Trump demands the U.S. pay no more for drugs than other countries … again

The problems with dementia villages

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Roivant's CEO is a star, but biotech's black hole persists

Sports medicine is finally prioritizing gender equality

J&J lung cancer data amount to new salvo against AstraZeneca

knowledge

Some of the ways extreme heat will change life as we know it

STAT Summit: How researchers deal with rejection

UnitedHealth, Optum discontinue NaviHealth name

Where are patients getting their prescriptions for GLP

Is there really a nursing shortage in the U.S.?

STAT Readout: Friday, Oct. 20 biotech updates

focus

Wikipedia

focus

knowledge